A phase II, randomized, open label trial of pre-operative (neoadjuvant) letrozole (Femara) vs. letrozole in combination with Avastin [bevacizumab] in post menopausal women with newly diagnosed operable breast cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Bevacizumab (Primary) ; Letrozole
- Indications Early breast cancer
- Focus Biomarker; Therapeutic Use
- 28 Feb 2018 Planned End Date changed from 1 Aug 2018 to 1 Jan 2020.
- 28 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
- 26 Oct 2017 Planned End Date changed from 1 Sep 2018 to 1 Aug 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History